Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen.

MLA

Cheng, A. L., et al. “Inhibition of the Membrane Translocation and Activation of Protein Kinase C, and Potentiation of Doxorubicin-Induced Apoptosis of Hepatocellular Carcinoma Cells by Tamoxifen.” Biochemical Pharmacology, vol. 55, no. 4, Feb. 1998, pp. 523–31. EBSCOhost, https://doi.org/10.1016/s0006-2952(97)00594-7.

APA

Cheng, A. L., Chuang, S. E., Fine, R. L., Yeh, K. H., Liao, C. M., Lay, J. D., & Chen, D. S. (1998). Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen. Biochemical Pharmacology, 55(4), 523–531. https://doi.org/10.1016/s0006-2952(97)00594-7

Chicago

Cheng, A L, S E Chuang, R L Fine, K H Yeh, C M Liao, J D Lay, and D S Chen. 1998. “Inhibition of the Membrane Translocation and Activation of Protein Kinase C, and Potentiation of Doxorubicin-Induced Apoptosis of Hepatocellular Carcinoma Cells by Tamoxifen.” Biochemical Pharmacology 55 (4): 523–31. doi:10.1016/s0006-2952(97)00594-7.